Login  |  Register

Investigation Report on China Imatinib Market, 2009-2018

Imatinib was approved to China in 2002 to treat CML and GIST. Its market size keeps increasing after its launch. According to CRI's investigation on sample hospital ...

Alexa Traffic


Listing Links